MicroRNA-485-5p targets keratin17 to regulate pancreatic cancer cell proliferation and invasion via the FAK / SRC / ERK pathway

被引:2
|
作者
Chen, Peng [1 ]
Pan, Meng [1 ]
Shen, Zhengchao [2 ]
Yang, Yuquan [1 ]
Wang, Xiaoming [2 ]
机构
[1] Wannan Med Coll, Affiliated Hosp 2, Dept Hepatobiliary Surg, Wuhu 241000, Anhui, Peoples R China
[2] Wannan Med Coll, Affiliated Hosp 1, Dept Hepatobiliary Surg, Wuhu 241001, Anhui, Peoples R China
来源
JOURNAL OF CANCER | 2024年 / 15卷 / 07期
关键词
Pancreatic cancer; KRT17; MiRNA-485-5p; Cell cycle; Proliferation; FOCAL ADHESION KINASE; KRT17; PROGRESSION; MIR-485-5P; KNOCKDOWN; CYCLE;
D O I
10.7150/jca.90689
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: It is crucial to probe into the biological effect and mechanism of miRNA-485-5p regulating keratin 17 (KRT17) in pancreatic cancer (PC) to understand its pathogenesis and identify potential biological targets. Methods: The bioinformatics means were used to evaluate the clinical significance of KRT17 expression in the Cancer Genome Atlas (TCGA) database. TargetScan database analysis in conjunction with dual luciferase and RNA Immunoprecipitation (RIP) experiments was used to probe the interaction relationship of miRNA-485-5p with KRT17. The expression of miRNA-485-5p and KRT17 in PC tissue and cancer cell lines was detected by Q-PCR paired with western blot assay. The biological function of miRNA-485-5p in regulating KRT17 was investigated in the PC cell line via gene silencing/overexpression technique. A western blot experiment was utilized to investigate the regulatory effect of KRT17 on cell cycle-related proteins and the FAK/Src/ERK signal pathway. Results: The level of KRT17 was increased in PC tissues and this significantly decreased the survival rate of PC patients. TargetScan in combination with dual luciferase and RIP experiments verified the miRNA-485-5p target KRT17. The expression of KRT17 was high in the PC cell line, although the expression of miRNA-485-5p was low. Silencing KRT17 or overexpression of miRNA-485-5p significantly inhibited PC cell viability, proliferation, invasion, and colony formation, while promoting apoptosis. Overexpression of KRT17 drastically reversed the function of miRNA-485-5p. The silenced KRT17 remarkably downregulated the expression of cyclinD1, Cyclin Dependent Kinase 1 (CDK1), CDK2, Phospho-Focal Adhesion Kinase (p-FAK), p-Src, and p-ERK proteins in the PC cells. Conclusion: Generally, an essential signaling cascade of miRNA-485-5p/KRT17/FAK/Src/ERK influences the biological functions of PC cells.
引用
收藏
页码:2033 / 2044
页数:12
相关论文
共 35 条
  • [31] A novel long non-coding RNA TTN-AS1/microRNA-589-5p/FOXP1 positive feedback loop increases the proliferation, migration and invasion of pancreatic cancer cell lines
    Zhao, Jing
    Wu, Fang
    Yang, Jun
    ONCOLOGY LETTERS, 2021, 22 (05)
  • [32] Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway
    Xiangpeng Meng
    Jia Ma
    Baosheng Wang
    Xin Wu
    Zhen Liu
    Journal of Physiology and Biochemistry, 2020, 76 : 301 - 315
  • [33] Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway
    Meng, Xiangpeng
    Ma, Jia
    Wang, Baosheng
    Wu, Xin
    Liu, Zhen
    JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2020, 76 (02) : 301 - 315
  • [34] MiR-450a-5p Inhibits Gastric Cancer Cell Proliferation, Migration, and Invasion and Promotes Apoptosis via Targeting CREB1 and Inhibiting AKT/GSK-3β Signaling Pathway
    Zhao, Ya-Jun
    Zhang, Jun
    Wang, Yong-Cang
    Wang, Liang
    He, Xin-Yang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [35] Signal Transducer and Activator of Transcription 4-Induced Up-Regulated LINC01278 Enhances Proliferation and Invasion of Non-Small Cell Lung Cancer Cells via the MicroRNA-877-5p/Activating Transcription Factor 4 Axis
    Yang, LinZhu
    Xiao, Yi
    Deng, ShouJun
    Yan, DaiLing
    Li, ZhenHua
    Wang, Ying
    Lei, ChangCheng
    TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2024, 21 (04) : 595 - 608